News by Subject Education

A recent study assessing the relationship between nursing specialty certification rates and surgical site infections (SSI) provides an innovative option for future research exploring relationships between nursing and hospital procedures and medical and/or surgical adverse events.

The Lyda Hill Foundation, in partnership with Geena Davis's Institute on Gender in Media at Mount Saint Mary's University, released an extensive research report on the portrayals of female characters in science, technology, engineering and math in television and film. 'Portray Her: Representations of Women STEM Characters in Media' shows that entertainment media has a long way to go to improve stereotypes about pursuing STEM careers.

A new academic study, the first of its kind, reveals a significant and positive historical legacy of Protestant religion in education around the world.

A new study, led by UNSW Sydney PhD student Rose O'Dea, has explored patterns in academic grades of 1.6 million students, showing that girls and boys perform very similarly in STEM - including at the top of the class.

The first randomized trial of its kind was unable to establish non-inferiority of oral anticoagulation (OAC) alone to combined OAC and a single antiplatelet agent (APT) in patients with atrial fibrillation (AF) and stable coronary artery disease beyond one year after stent implantation.

Results from the Lipid-Rich Plaque (LRP) study demonstrate the correlation between the presence of non-flow-limiting, non-intervened upon, lipid-rich plaques detected by NIRS-IVUS imaging and the development of a major adverse cardiac event (MACE) from a de novo culprit lesion at both the patient level (vulnerable patients) and segment level (vulnerable plaques) within 24 months post intravascular imaging.

The first study designed to determine the benefits of intravascular ultrasound (IVUS) guidance over angiography guidance during drug-eluting stent (DES) implantation in all-comer patients found that IVUS improved clinical outcomes by lowering the rate of target vessel failure at one year.

The first large, randomized trial comparing a novel polymer-free amphilimus-eluting stent to the latest-generation permanent polymer drug-eluting stent found that the polymer-free stent was clinically safe and effective.

This first randomized clinical study of a polymer-coated zotarolimus-eluting stent (Resolute Onyx) that utilizes a novel thin-strutted metallic platform allowing for better x-ray visibility was shown to be non-inferior to an ultrathin-strutted bioresorbable polymer-coated sirolimus-eluting stent (Orsiro) that uses a cobalt-chromium strut platform.